BTB Therapeutics provides research, development support, and consulting services for new drugs.
BTB Therapeutics has raised $3.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
BTB Therapeutics's investors include SMBC Venture Capital, Kyoto University Innovation Capital.
BTB Therapeutics is headquartered in Escondido, United States.
BTB Therapeutics provides research, development support, and consulting services for new drugs.
BTB Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BTB Therapeutics — Funding & Investors." VCBacked, November 30, 2025, https://www.vcbacked.co/company/btb-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). BTB Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/btb-therapeutics
{{cite web |title=BTB Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/btb-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated